Veracyte Publishes First Studies Using Afirma GRID for Next-Gen Thyroid Testing

Veracyte Unveils Landmark Studies Using Afirma GRID to Advance Next-Generation Thyroid Nodule Testing Veracyte, Inc. (Nasdaq: VCYT), a leader in genomic diagnostics, has announced the publication of two groundbreaking research studies demonstrating how its Afirma GRID (Genomic Resource for Intelligent…










